February 22, 2024
Breast Reconstruction market

Market Is Estimated To Witness Moderate Growth Owing To Increasing Incidence Of Breast Cancer & Rising Cosmetic Surgeries

The breast reconstruction market is estimated to be valued at US$ 589 million in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Breast reconstruction involves surgical procedures that recreate a breast shape after mastectomy or breast reduction surgery. There are two main types of breast reconstruction – implant-based reconstruction using silicone implants or tissue expanders, and autologous reconstruction using tissue flap methods that use a woman’s own tissue from other parts of her body. Implant-based reconstruction is the most commonly performed procedure as it has shorter surgery time and recovery period compared to autologous methods.

Market Dynamics:

The breast reconstruction market is driven by the increasing incidence of breast cancer worldwide. According to the World Health Organization (WHO), breast cancer is the most common cancer in women, impacting 2.3 million women each year globally. Mastectomy is a common breast cancer treatment procedure which often leads to reconstruction of breasts for better psychosocial wellbeing and confidence of women. Furthermore, the market growth is also fuelled by the rising number of cosmetic breast surgeries being performed to enhance aesthetic appearance. Younger women are increasingly opting for cosmetic breast operations owing to influential social media and growing self-esteem issues. Also, technological advancements in reconstruction methods and new product launches by key players are positively impacting the market expansion. For instance, anatomical shape breast implants launched by leading manufacturers provide a more natural look and feel.

SWOT Analysis

Strength: Breast reconstruction market has strong expertise and technical knowledge. Many new techniques and implants have been developed to provide better aesthetic results with minimal scarring. There is a wide range of implant sizes and shapes available to closely match each patient’s body. Reconstruction procedures can restore confidence and improve quality of life for women.
Weakness: Reconstruction surgeries require long recovery time and multiple procedures in some cases. Cost of surgery and prolonged recovery can be financially and physically challenging for some patients. Breast implants may need to be replaced every 10-15 years which requires additional surgery.
Opportunity: Growing awareness about breast reconstruction options can encourage more women to undergo the procedure. Also, rising female geriatric population prone to breast cancer indicates potential market growth opportunities. Medical tourism in developing countries offers lucrative business potential.
Threats: Strict regulations surrounding breast implant safety may increase cost of compliance for companies. Growing ‘going flat’ trend where women choose not to undergo reconstruction post mastectomy is a threat. Emergence of non-surgical breast enhancement methods can divert patients.

Key Takeaways

The Global Breast Reconstruction Market Growth  is expected to witness high, exhibiting CAGR of 2.7% over the forecast period, due to increasing incidence of breast cancer cases worldwide. According to statistical reports, over 2 million new breast cancer cases were reported in 2020.

Regional analysis:
North America dominates the breast reconstruction market accounting for over 35% of global revenue. This is attributed to rising public health awareness campaigns for early disease detection in the region coupled with favourable reimbursement policies for reconstruction procedures. Asia Pacific exhibits fastest growth supported by growing medical tourism industry in countries like India, China and Thailand.

Key players:
Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. These companies focus on new product launches and geographic expansion to strengthen their market positions.

 

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it